| Scorecard |
|---|
|
2 / 5 Stars
|
|
Lipper
3
3
3
3
2
|
|
Zacks Investment Research
3
(Hold)
|
|
Standard & Poor's
1 / 5 Stars
|
|
TheStreet.com
D
(Sell)
|
Fund Holdings
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 13.26 | 8.96 | 4.3 |
| Stocks | 58.89 | 0.0 | 58.89 |
| Bonds | 0.05 | 0.0 | 0.05 |
| Other | 9.48 | 1.13 | 8.34 |
| Foreign Bonds | 0.01 | 0.0 | 0.01 |
| Foreign Stocks | 24.8 | 0.0 | 24.8 |
| Convertible | 0.01 | 0.0 | 0.01 |
| Preferred | 3.61 | 0.0 | 3.6 |
Updated 01.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 01.31.2013
| % Net Assets | |
|---|---|
| Guggenheim S&P 500 Equal Weight | 5.73 |
| PowerShares Dynamic Pharmaceuticals | 4.51 |
| iShares PHLX SOX Semiconductor Sector | 4.15 |
| iShares S&P U.S. Preferred Stock Index | 4.15 |
| Market Vectors Wide Moat ETF | 3.68 |
| iShares Dow Jones Intl Select Div Idx | 3.4 |
| PowerShares DB G10 Currency Harvest | 3.4 |
| PowerShares Global Listed Private Eq | 3.24 |
| EGShares Emerging Markets Consumer | 3.03 |
| PowerShares DB Gold | 2.94 |
